Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Regen BioPharma (RGBPP) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Regen BioPharma (RGBPP) over the last 11 years, with Q4 2025 value amounting to $200.0.

  • Regen BioPharma's Prepaid Assets fell 9960.98% to $200.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $200.0, marking a year-over-year decrease of 9960.98%. This contributed to the annual value of $200.0 for FY2025, which is 9958.13% down from last year.
  • Regen BioPharma's Prepaid Assets amounted to $200.0 in Q4 2025, which was down 9960.98% from $200.0 recorded in Q3 2025.
  • In the past 5 years, Regen BioPharma's Prepaid Assets registered a high of $51250.0 during Q4 2024, and its lowest value of $4.0 during Q1 2021.
  • Moreover, its 5-year median value for Prepaid Assets was $10000.0 (2023), whereas its average is $17591.1.
  • Per our database at Business Quant, Regen BioPharma's Prepaid Assets soared by 86445000.0% in 2022 and then plummeted by 9960.98% in 2025.
  • Over the past 5 years, Regen BioPharma's Prepaid Assets (Quarter) stood at $41288.0 in 2021, then tumbled by 65.88% to $14089.0 in 2022, then tumbled by 64.51% to $5000.0 in 2023, then surged by 925.0% to $51250.0 in 2024, then plummeted by 99.61% to $200.0 in 2025.
  • Its last three reported values are $200.0 in Q4 2025, $200.0 for Q3 2025, and $200.0 during Q2 2025.